以下公司将在本届ChinaBio®创业投资论坛2010 - 广州展出.
The Balloch Group ("TBG") was established in 2001 by Howard Balloch (Canada's ambassador to China from 1996 to 2001). TBG has since grown from a market-entry consultancy working with North American clients in China to a leading advisory and merchant banking firm serving both domestic Chinese companies and multinational corporations. TBG was ranked as the number one boutique investment bank in China by ChinaVenture in 2008. TBG's professionals are located in Beijing, New York, Shanghai, Hong Kong, Wuhan and Hangzhou serving and investing alongside our clients in mergers and acquisitions, capital markets and direct investment transactions. www.ballochgroup.com
Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of initiatives accelerating the globalization of China’s life science industry. ChinaBio has helped China companies raise over $350 million and global life science companies identify over 400 licensing and acquisition opportunities in China.
- Conferences: ChinaBio organizes the premier life science investment and partnering conferences in China, having attracted over 4,000 attendees.
- Consulting: ChinaBio works with global life science companies and China entrepreneurs to define and execute a successful global strategy.
- Transactions: ChinaBio helps companies secure partnerships and acquisitions and access private and government funding in China.
- Publishing: ChinaBio® Today is the most widely read online and email newsletter on China’s life science industry.
More information is available at www.ChinaBioLLC.com.
Cyagen Biosciences was established to develop technologies in stem cell research, genetic engineering and transgenic animal research to serve the growing needs from life sciences labs and drug discovery companies. The principals of Cyagen consist of world-class scientists, senior industry experts and professional managers from both the U.S. and China. Cyagen's 1600 square meter main R&D and production facility is located in the Science City on the outskirt of Guangzhou, encompassing a laminar flow ultra-clean cell culture lab built to GMP standard, a molecular biology lab, and an animal barrier facility housing mice and rats intended for transgenic and gene knockout research. The business philosophy of Cyagen is to create a competitive advantage by marrying cutting-edge technologies in the U.S. with cost effectiveness R&D in China, and to use this advantage to bring top-quality reagents, tools and services to researchers around the world at favorable prices. www.cyagen.com
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website:www.lifetechnologies.com